Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry

Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry

Journal Title: 
Am J Hematol
Primary Author: 
Lee JW
Author(s): 
Lee JW, Peffault de Latour R, Brodsky RA, Jang JH, Hill A, Röth A, Schrezenmeier H, Wilson A, Marantz JL, Maciejewski JP.
Original Publication Date: 
Tuesday, January 1, 2019
Full Article on PubMed: 
https://www.ncbi.nlm.nih.gov/pubmed/30370949/

No abstract available

Bone Marrow Disease(s): 
  • aplastic anemia
  • paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.